IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,029,340 | -16.2% | 210,731 | -7.4% | 0.02% | -8.3% |
| Q2 2023 | $2,420,238 | -13.6% | 227,466 | -14.6% | 0.02% | -11.1% |
| Q1 2023 | $2,802,370 | -7.7% | 266,385 | +8.7% | 0.03% | 0.0% |
| Q4 2022 | $3,035,154 | +9.6% | 244,968 | -8.4% | 0.03% | +28.6% |
| Q3 2022 | $2,769,000 | -7.5% | 267,316 | +2.9% | 0.02% | 0.0% |
| Q2 2022 | $2,995,000 | -8.9% | 259,727 | -0.6% | 0.02% | +10.5% |
| Q1 2022 | $3,287,000 | +7.3% | 261,327 | -0.5% | 0.02% | 0.0% |
| Q4 2021 | $3,064,000 | +11.3% | 262,746 | +24.7% | 0.02% | -20.8% |
| Q3 2021 | $2,752,000 | +38.6% | 210,731 | +36.5% | 0.02% | +41.2% |
| Q2 2021 | $1,986,000 | +118.2% | 154,327 | +52.5% | 0.02% | +70.0% |
| Q3 2020 | $910,000 | – | 101,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |